{"id":"W4404091899","doi":"10.1093/brain/awae277","title":"Phase 2b program with sonlicromanol in patients with mitochondrial disease due to m.3243A>G mutation","year":2024,"lang":"en","type":"article","venue":"Brain","topic":"Phytochemistry and Biological Activities","field":"Agricultural and Biological Sciences","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"HORIZON EUROPE European Innovation Council; Julius Clinical; HORIZON EUROPE Framework Programme; Bundesministerium für Bildung und Forschung; E-Rare","keywords":"Tolerability; Medicine; Randomized controlled trial; Placebo; Mitochondrial disease; Clinical endpoint; Internal medicine; Adverse effect; Pathology; Mitochondrial DNA; Biology; Genetics","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002478644,0.001426756,0.002169595,0.0006826138,0.000502393,0.0006234174,0.0007340299,0.00161877,0.007213185],"category_scores_gemma":[0.001596311,0.0005919066,0.001527205,0.0002888393,0.0007063938,0.0007162085,0.0006407437,0.002154164,0.001148519],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006674684,"about_ca_system_score_gemma":0.001607994,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006943968,"about_ca_topic_score_gemma":0.001421605,"domain_scores_codex":[0.9992537,0.0004314036,0.00003831873,0.00009177154,0.00005129246,0.0001334442],"domain_scores_gemma":[0.998988,0.0002158822,0.0001956199,0.0001156117,0.0001154407,0.0003695154],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8585083,0.06356916,0.002514679,0.0006449582,0.0005390325,0.0001690022,0.000145143,0.0009012306,0.0186656,0.0003102841,0.002067155,0.05196553],"study_design_scores_gemma":[0.6197132,0.3713345,0.00368985,0.00003400846,0.0001883055,0.00008093058,0.00003247373,0.0003990147,0.001952522,0.0001462694,0.002412013,0.00001697986],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9673429,0.001638485,0.001512301,0.0006836104,0.0002191814,0.02468982,0.001779221,0.000149193,0.001985229],"genre_scores_gemma":[0.930915,0.002000494,0.006608469,0.001753135,0.0005195178,0.04891216,0.003009164,0.0000539982,0.006228072],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007213185,"threshold_uncertainty_score":0.02413046,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01180638655148963,"score_gpt":0.2452301547637352,"score_spread":0.2334237682122456,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}